Share this story:

Ventripoint Announces Postponement of First Quarter Filings



Ventripoint Diagnostics Ltd.
 

Toronto, Ontario – TheNewswire - May 29, 2020 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation), (TSXV:VPT)  wishes to announce that the Company is postponing the reporting of its first quarter Financial Statements and Management’s Discussion and Analysis (“MD&A”) as a result of delays caused by the COVID-19 pandemic. The Company aims to file these documents by the end of June 2020 under the terms of the 45-day extension announced by the Ontario Securities Commission under the “Ontario Instrument 51- 502”, dated March 23, 2020. The Company ratifies that management and the Company's insiders remain subject to the Company's Insider Trading Policy and confirms that there have been no material business developments since April 2020 when the Company filed its annual audited financial results other than as announced.

About Ventripoint Diagnostics Ltd.

Ventripoint’s technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound.  The Corporation has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.

 

For further information, please contact:

Dr. George Adams, Executive-Chaiman, Telephone: (519) 803-6937

Email: gadams@ventripoint.com

 

Forward Looking Statements:

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. In particular, this news release contains forward-looking information relating to the Offering and the use of the proceeds therefrom. The forward-looking statements and information are based on certain key expectations and assumptions made by the Corporation, including expectations and assumptions concerning the use of net proceeds of the Offering. Although the Corporation believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward looking statements and information because the Corporation can give no assurance that they will prove to be correct.

Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Such factors which could materially affect such forward-looking information are described in the risk factors in the Corporation's most recent annual management’s discussion and analysis that is available on the Corporation’s profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.